14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
Jan 26, 2016 $18.60 $18.79 $17.51 $18.56 2 754 100
Jan 25, 2016 $18.70 $19.34 $18.27 $18.46 2 456 100
Jan 22, 2016 $18.87 $19.32 $18.54 $18.85 2 400 300
Jan 21, 2016 $19.09 $19.60 $18.01 $18.40 3 900 900
Jan 20, 2016 $17.16 $19.50 $16.77 $19.05 4 583 700
Jan 19, 2016 $18.90 $18.90 $17.13 $17.72 4 943 100
Jan 15, 2016 $17.37 $18.49 $16.90 $18.37 4 600 200
Jan 14, 2016 $17.57 $18.91 $16.49 $18.51 5 039 500
Jan 13, 2016 $19.87 $20.12 $17.36 $17.45 4 843 900
Jan 12, 2016 $19.20 $20.25 $18.60 $19.21 5 247 900
Jan 11, 2016 $19.04 $19.13 $17.32 $18.09 4 584 600
Jan 08, 2016 $20.06 $20.06 $18.52 $18.99 3 605 200
Jan 07, 2016 $20.25 $20.35 $19.22 $19.59 3 814 600
Jan 06, 2016 $20.91 $21.61 $20.70 $20.94 2 604 200
Jan 05, 2016 $21.32 $22.02 $21.12 $21.53 2 829 100
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT